The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports
Monkeypox Virus Test Could Yield Revenue for Its Creator
Research Report
The Utah-based diagnostics firm has multiple shots on goal with this specific molecular test and with its convenient, fast testing platform, both in development, noted an H.C. Wainwright & Co. report.
FDA Approves New Skin Resurfacing Device
Apyx Medical Corp. shares traded 50% higher after the company reported it received U.S. FDA 510(k) clearance for its Renuvion Dermal Handpiece for use in specific cosmetic dermal resurfacing procedures.Ophthalmic Med Tech. Firm Sees 166% Gain in LAL Implants
Shares of RxSight Inc. traded 7% higher after the company reported Q1/22 financial results which highlighted a 157% YoY increase in revenue and a 208% increase in unit sales of its Light Delivery Devices (LDD™s) utilized in cataract surgery procedures to implant its RxSight Light Adjustable Lens® (LAL), which it says is "the world's first and only adjustable intraocular lens (IOL) that is customized after cataract surgery."Is Reliq Health Technologies a Nutrimental 'Buy'?
Contributed Opinion
After recovering from a short "character assassination," Reliq Health Technologies may be on the up-and-up. Clive Maund examines the latest data from the company to see if it would make a good 'buy'.
Co. to Rebound After Q4/21 Sales Down Due to Virus Surge
Research Report
The 2022 outlook for a cancer detection and therapy solutions company is positive given its focus on dermatology and implementing new commercial strategies, noted an Oppenheimer report.
Imaging Diagnostics Co.'s Shares Rise 35% on FY21 Earnings
Lantheus Holdings Inc. shares traded to a new 52-week high after the firm reported Q4/21 and FY/21 financial results that included a 25.3% increase in annual revenue. The firm also advised that the FDA approved the sNDA for its isolator-based drug manufacturing facility for diagnostic ultrasound enhancing agent DEFINITY® for patients in the U.S. with suboptimal echocardiograms.Dialysis Equip. Co. Posts Record FY21 Sales
Shares of a wireless mobile dialysis equipment maker traded 15% higher after the company reported FY/21 financial results highlighting a 105% YoY increase in revenue to $102.6 million.FDA Approves First Tubeless Insulin Delivery Device
Shares of Insulet Corp. traded 15% higher after the company reported its Omnipod® 5 automated insulin delivery system has received clearance from the U.S. FDA. The Omnipod® 5 is the first tubeless system to be monitored and controlled remotely using a smartphone.Biotech Could Launch Trial of Polyp Screening Test in March
Research Report
The start of the C-Scan study would be a major milestone for Check-Cap, noted an H.C. Wainwright & Co. report.
Co.'s COVID-19 Test Detects Omicron Variant
Research Report
H.C. Wainwright & Co. gives Sorrento Therapeutics a Buy rating after initial testing shows its COVISTIX detects COVID-19's Omicron variant.
Showing Results: 1 to 10 of 10